Clinical Trials

7 enrolled 15 charts

Neoplasms

NCT05148078 2026-03-02

Pediatric Radiation Oncology With Movie Induced Sedation Effect (PROMISE)

30 enrolled 10 charts

Neoplasms

NCT05024968 2026-02-25

Sintilimab in Cancer of Unknown Primary

10 enrolled 9 charts

Neoplasms, Unknown Primary

NCT04150900 2026-02-19

1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck

7 enrolled 11 charts

Carcinoma, Squamous Cell

NCT03388190 2026-02-13

METIMMOX

80 enrolled 13 charts

Neoplasm Metastasis, Neoplasms

NCT03964727 2026-01-30

TROPiCS-03

223 enrolled 31 charts

Neoplasm Metastasis

NCT03697304 2026-01-27

Platform Trial Evaluating Safety and Efficacy of Ezabenlimab Anti- PD-1 Based Combination Therapies in PD-(L)1 naïve and PD- (L)1 Pretreated Patient Populations With Advanced/Metastatic Solid Tumours

211 enrolled 23 charts

Neoplasm Metastasis

NCT03872427 2025-11-14

Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study

54 enrolled 12 charts

Neoplasm Metastasis

NCT04639219 2025-10-16

DPT01

102 enrolled 18 charts

Neoplasm Metastasis

NCT06926673 2025-07-03

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 3

62 enrolled 36 charts

Neoplasms

NCT06790303 2025-06-04

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2

8 enrolled 11 charts

Neoplasms

NCT04808999 2025-05-29

Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC)

30 enrolled 10 charts

Carcinoma, Squamous Cell

NCT01871441 2025-05-16

Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies

4 enrolled 10 charts

Neoplasms

NCT03570619 2025-05-08

IMPACT

56 enrolled 18 charts

Neoplasm Metastasis

NCT04014075 2025-04-03

DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02)

79 enrolled 19 charts

Neoplasm Metastasis

NCT05126433 2025-02-28

JAZZ EMERGE201

47 enrolled 16 charts

Neoplasm Metastasis

NCT00748709 2025-02-11

Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification.

20 enrolled 11 charts

Neoplasms

NCT04812535 2025-02-11

Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.

30 enrolled 41 charts

Neoplasm Metastasis

NCT04187833 2025-01-14

Nivolumab in Combination With Talazoparib in Melanoma and Mutations in BRCA or BRCA-ness Genes

8 enrolled 12 charts

Neoplasm Metastasis

NCT01650194 2024-12-10

A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients

60 enrolled 24 charts

Neoplasms

NCT03760081 2024-11-13

A Study to Assess the Safety and Efficacy of ASP1650, a Monoclonal Antibody Targeting Claudin 6 (CLDN6), in Male Subjects With Incurable Platinum Refractory Germ Cell Tumors

19 enrolled 19 charts

Neoplasms

NCT04534283 2024-08-07

A Basket Trial of an ERK1/2 Inhibitor (LY3214996) in Combination With Abemaciclib.

16 enrolled 11 charts

Neoplasm Metastasis, Neoplasms

NCT03094286 2024-06-24

Durvalumab in HIV-1 Patients With Solid Tumors

20 enrolled 36 charts

Neoplasms

NCT02640508 2024-05-09

Eribulin and Lenvatinib in Advanced Solid Tumors

29 enrolled 13 charts

Neoplasms

NCT04738292 2024-05-03

Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)

11 enrolled 10 charts

Neoplasm Metastasis

NCT03396471 2024-04-18

Study of Pembrolizumab and Concurrent Radiation in Patients With Previously Treated Carcinoma of Unknown Primary

14 enrolled 17 charts

Carcinoma

NCT03997448 2024-02-20

Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149

3 enrolled 10 charts

Adenocarcinoma

NCT04894994 2023-12-05

FLX475 in Combination With Ipilimumab in Advanced Melanoma

6 enrolled 10 charts

Neoplasms

NCT03308942 2023-10-16

Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants

53 enrolled 35 charts

Neoplasms

NCT02478320 2023-07-17

Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors

12 enrolled 11 charts

Neoplasm Metastasis

NCT02412670 2023-07-10

Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer

36 enrolled 14 charts

Carcinoma

NCT01746225 2023-06-01

SNAP

258 enrolled 17 charts

Neoplasm Metastasis, Neoplasms

NCT02213133 2023-01-26

STARRS

45 enrolled 12 charts

Carcinoma, Carcinoma, Squamous Cell

NCT05553808 2023-01-19

Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 1

105 enrolled 31 charts

Neoplasms

NCT02915783 2023-01-17

A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease

41 enrolled 11 charts

Neoplasm Metastasis

NCT02576444 2022-12-28

OLAPCO

67 enrolled 10 charts

Neoplasms

NCT02921919 2022-08-24

Open-Label Extension and Safety Study of Talazoparib

120 enrolled 16 charts

Neoplasms

NCT02920476 2022-06-23

UF-STO-LUNG-003

4 enrolled 8 charts

Carcinoma, Neoplasm Metastasis

NCT04003623 2022-05-10

Efficacy and Safety of Pemigatinib in Participants With Solid Tumors With FGFR Mutations or Translocations (FIGHT-208)

1 enrolled 2 charts

Neoplasm Metastasis

NCT02832167 2022-05-09

CheckMate 627

239 enrolled 22 charts

Neoplasms

NCT03000179 2022-04-14

Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma

8 enrolled 12 charts

Adenocarcinoma

NCT03271047 2022-01-04

Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation

75 enrolled 17 charts

Neoplasms

NCT01660711 2021-11-08

A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma

22 enrolled 8 charts

Adenocarcinoma, Neoplasms

NCT03097588 2021-07-12

Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant

43 enrolled 18 charts

Neoplasms

NCT00545129 2021-06-18

A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone

59 enrolled 32 charts

Neoplasm Metastasis

NCT02458638 2021-06-04

A Study of Atezolizumab in Advanced Solid Tumors

474 enrolled 14 charts

Neoplasms

NCT03875859 2021-05-20

Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)

4 enrolled 9 charts

Carcinoma, Squamous Cell

NCT01238120 2021-05-05

The Effects of Physical Activity and Low-Dose Ibuprofen on Cognitive Function in Cancer Patients

110 enrolled 15 charts

Neoplasms

NCT02213289 2021-04-08

PANGEA-IMBBP: Personalized Antibodies for Gastro-Esophageal Adenocarcinoma - A 1st Pilot Metastatic Trial of Biologics Beyond Progression

80 enrolled 14 charts

Adenocarcinoma

NCT01206296 2021-03-09

Adjuvant Intraperitoneal Gemcitabine for Resectable Pancreatic Adenocarcinoma

9 enrolled